Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea

Slides:



Advertisements
Similar presentations
TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.
Advertisements

World Health Organization TB Case Definitions
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Module 3: Final Case Study # 3-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 3-CS-2.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Outcomes among patients treated for tuberculosis in Limpopo Province, South Africa, Mmakgotso Pilane, Lazarus Kuonza, Eric Maimela.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Monitoring and Evaluation Module 12 – March 2010.
Mpumalanga Department of Health report on Comprehensive HIV and AIDS Grant 1.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
Progress of the Singapore TB Elimination Programme (STEP)
ACTION PLAN FOR TUBERCULOSIS CONTROL PAPUA NEW GUINEA DR. JOSEPH BANA-KOIRI.
Sri Lankan Perspective Dr Nihal Abeysinghe M.B.,B.S., MSc, M.D. (Community Medicine) Chief Epidemiologist Ministry of Health, Nutrition & Welfare Place.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
New technology for an old disease
Monitoring and Evaluation: A Review of Terms
TB- HIV Collaborative activities in Romania- may 2006 status
Prisons and TB in Europe
Country Progress Report Cambodia
Daffodil International University (DIU), Dhaka Bangladesh
RNTCP implementation status Population (in million)
PROGRESS IN GLOBAL TB CONTROL
The burden of TB in the Western Pacific
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
TB-HIV Last updated: November 2018.
TUBERCULOSIS SURVEILLENCE KENYA
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
3rd Global WG on TB/HIV, Montreux, 4-6 June, 2003
Buhera District.
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
WS on Surveillance & Epidemiology
Papua New Guinea.
Review of Wednesday 5th May
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
National Tuberculosis Control Program Department of Health Philippines Dr. Vivian S. Lofranco Medical Specialist IV.
Cheng shiming National TB Center in China May,3, 2004
Uganda TB Surveillance data
Papua New Guinea.
National Tuberculosis Control Program in Vietnam
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Dr AKAKI Angennes; Dr SAN Koffi / NTCP
EXERCISE 11: Computing and Analyzing Program Indicators
Objectives of the workshop
TB epidemiology in Bulgaria
Papua New Guinea.
Epidemiology of Tuberculosis in Hong Kong
PROGRESS IN GLOBAL TB CONTROL
Country Presentation CAMBODIA
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
TB notification in Hong Kong
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
Issues on the current information system
Country presentation Dr.Vija Riekstina National TB registry
Indicators, Data Sources and Data Quality for TB M&E
Routine Counselling and HIV testing (CT) for TB patients in Malawi: Rhehab Chimzizi TB-HIV Programme officer National TB Control Programme-Malawi.
Monitoring and Evaluation: A Review of Terms
Belize Presentation Dr. Ines Mendez-Moguel
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Presentation transcript:

Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea Workshop on Surveillance and Epidemiology of Tuberculosis in the Western Pacific Region, Manila, Philippines,4-7 May 2004 Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea

Country

Population 5.1 Million(2,000 Census) Melanesian & Polynesian 85% Rural Languages: 817 3 Official-English,Pidgin & Motu

Health Indicators of PNG Leading Causes of Death Life expectancy 54(2000) IMR 64 per 1000 births(2000) MMR 370 per 100,000 births(1996-DHS) TFR 4.7 Growth rate 2.3% Literacy rate 45%

EPIDEMIOLOGY OF TB IN PNG

DOTS coverage

Case-detection Target: minimum 70% of estimate Estimate: 115 new PTB+ cases / 100,000 / year Estimate is based on surveys, previous reporting, other countries, extrapolation DOTS case notification rate: number of new PTB+ cases notified / estimate

Notification Rates (status on 15 March 2004) 2001 2002 2003 TB07 expected 18 162 214 TB07 submitted 18 (100%) 160 (99%) 149 (70%) TB08 expected 8 TB08 submitted 8 (100%) 16 (89%) 90 (56%)

DOTS case-notification Number of new PTB+ cases notified in 2003: 859 for 5.1 million or 17/100,000 DOTS case notification rate: 17/115 or 15% for new smear-positive cases The true figure is higher as reporting is not complete

Treatment results Report is cohort based, i.e. it reviews the patient that were notified 12-15 months earlier. Possible outcomes: cured, treatment completed, died, failure, defaulter, transfer out, not evaluated Rates are calculated as: Number cured / number notified one year ago Separate analysis for new PTB+, new PTB-, relapse PTB+ and other PTB+ No evaluation of EPTB, retreatment PTB-

Treatment Results: new P+TB (status on 15 March 2004) Cohort: 403 452 934

Treatment Results: new P-TB (status on 15 March 2004) Cohort: 1064 1505 2057

Treatment outcomes (percents) 1998 1999 2000 2001 2002 Cured Completed 21 25.5 32.9 29.8 36.5 Defaulted Failed 1.9 2.5 3.3 3 3.1 Died Transferred out 2.9 2.6 2.1 2.4 4 Non evaluated

Incidence of HIV at Antenatal, TB and STI Clinic Site No. of Patients Screened No. of Sero-Conversion Prevalence Rate(%) Port Moresby   Antenatal 1187 16 1.35 STI Clinic 335 27 8.06 TB Clinic 300 57 19.00 Goroka 451 4 0.89 315 5 1.59 Mt. Hagen 19 6.33 Lae 480 12 2.50 Daru 150 1 0.66   Source: HIV/AIDS Quarterly Report, Sept. 2003-Department of Health, PNG

NHIS REPORTING RATE It is possible that inconsistencies may arise with data used for analysis at province level and those at national level (for example, if reports are not forwarded, or errors in data entry are not identified). Provinces are urged to collate and undertake their own analysis; however, the national level report will be extracted from the Nation Department of Health. Failure to submit reports will limit the ability of the national report to accurately provide the picture of provincial performance. The higher the report returns, the more likely is the national report likely to reflect the actual situation. Accordingly, health centre, district and province staff are encouraged to enter their data and forward reports with a high level of efficiency and quality. The NHIS return rates below show that overall, the national report is drawn from reports form only 89% of health facilities, and in some province, a quarter of the facility reports are not available.

Surveys No Prevalence Survey Done No Tuberculin Survey No skills and personnel to do it No financial backing Logistic is difficult Government Reforms make it difficult No Tuberculin Survey

Monitoring of TB situation (DOTS) Each diagnosed case is registered – TB04 Each registered case is reported – TB07 Each reported case is analysed at the end of treatment (cohort) – TB08 TB is the only disease for which individual case-monitoring is systematically done

DOTS coverage: target 100% by 2007 Coverage refers to population covered A district or province is considered as DOTS covered when, after a formal training, one health facility in the district/province is submitting a TB07 report Number of health facilities reporting: 58 Number of districts reporting: 25 (28%) with 30% of pop. Number of provinces reporting: 9 (45%) with 46% of pop.

THANK YOU VERY MUCH EVERYONE FOR EVERY THING YOU HAVE DONE TO MAKE THIS WORKSHOP A VERY SUCCESSFUL ONE